Revolution Medicines (RVMDW) Change in Acquisitions & Divestments (2019 - 2026)

Revolution Medicines' Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $383.9 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 22.81% year-over-year to $383.9 million; the TTM figure through Mar 2026 stood at -$107.1 million (down 364.59% YoY), while the FY2025 annual figure was $6.4 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $383.9 million, up from -$491.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $1.3 billion in Q3 2024, with the low at -$1.3 billion in Q4 2024.
• The 5-year median for Change in Acquisitions & Divestments is $157.7 million (2022), against an average of $114.3 million.
• Peak annual rise in Change in Acquisitions & Divestments reached 415.76% in 2024, while the deepest fall reached 1010.83% in 2024.
• Revolution Medicines' Change in Acquisitions & Divestments stood at $156.1 million in 2022, then fell by 9.34% to $141.5 million in 2023, then sank by 1010.83% to -$1.3 billion in 2024, then surged by 61.91% to -$491.0 million in 2025, then surged by 178.19% to $383.9 million in 2026.
• Business Quant data shows RVMDW's Change in Acquisitions & Divestments at $383.9 million in Q1 2026, -$491.0 million in Q2 2025, and $497.4 million in Q1 2025.